Obsessive-compulsive disorder in Tourette syndrome

Area of Science:

• Neuroscience
• Psychiatry
• Genetics

Background:

• Obsessive-compulsive disorder (OCD) and Tourette syndrome (TS) exhibit significant overlap in comorbidity, phenomenology, and genetic factors.
• Basal ganglia circuitry is implicated in the pathophysiology of both conditions.
• Obsessive-compulsive behaviors in TS patients often manifest later than tics.

Purpose of the Study:

• To review the association between OCD and TS.
• To discuss distinct therapeutic approaches for tics and OCD symptoms.
• To outline current treatment guidelines for OCD, including pharmacotherapy and psychotherapy.

Main Methods:

• Literature review of studies investigating the relationship between OCD and TS.
• Analysis of treatment strategies for OCD, including cognitive behavior therapy (CBT) and pharmacotherapy.
• Evaluation of the efficacy and safety of serotonin reuptake inhibitors (SRIs) and adjunctive antipsychotics for OCD.

Main Results:

• First-line treatments for OCD include specialized CBT and potent SRIs, requiring an adequate trial of 10-12 weeks at high doses.
• Adjunctive low-dose antipsychotics (e.g., risperidone) may benefit patients with treatment-resistant OCD, irrespective of tic presence.
• While antidepressant use in youth carries suicidality warnings, the risk-benefit ratio favors SRIs for OCD due to demonstrated efficacy.

Conclusions:

• Despite shared underlying mechanisms, OCD and TS necessitate tailored treatment plans.
• SRIs are effective first-line treatments for OCD, with specific dosing and duration recommendations.
• Antipsychotics can serve as valuable adjuncts in managing refractory OCD cases.